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Recent studies using human pluripotent stem cells
(hPSCs) have developed protocols to induce kid-
ney-lineage cells and reconstruct kidney organoids.
However, the separate generation of metanephric
nephron progenitors (NPs), mesonephric NPs, and
ureteric bud (UB) cells, which constitute embryonic
kidneys, in in vitro differentiation culture systems
has not been fully investigated. Here, we create a cul-
ture system in which these mesoderm-like cell types
and paraxial and lateral platemesoderm-like cells are
separately generated from hPSCs. We recapitulate
nephrogenic niches from separately induced meta-
nephric NP-like and UB-like cells, which are subse-
quently differentiated into glomeruli, renal tubules,
and collecting ducts in vitro and further vascularized
in vivo. Our selective differentiation protocols should
contribute to understanding the mechanisms under-
lying human kidney development and disease and
also supply cell sources for regenerative therapies.
INTRODUCTION
In amniotes, the mesonephros is the embryonic kidney, and the
more complex metanephros acts as the adult kidney. The
mammalian metanephros develops by mutual interactions be-
tween two progenitor tissues, the ureteric bud (UB) and the
metanephric mesenchyme (MM) (Costantini and Kopan, 2010;
Taguchi et al., 2014). Several groups including ours have re-
ported induction protocols for kidney progenitor cells from hu-
man pluripotent stem cells (hPSCs) (Mae et al., 2018; Morizane
et al., 2015; Taguchi et al., 2014; Taguchi and Nishinakamura,
2017; Takasato et al., 2014, 2015; Toyohara et al., 2015; Xia
et al., 2013). Taguchi et al. (2014) found that inducing axial
stem cells and the posterior intermediate mesoderm (IM) could
facilitate the derivation of metanephric nephron progenitors
(NPs) by using an embryoid body culture system. Morizane
et al. (2015) induced metanephric NPs at high efficiency in
two-dimensional (2D) cultures. Takasato et al. (2015) have
generated kidney organoids by simultaneously inducing MM
and UB lineages. Taguchi and Nishinakamura (2017) succeeded
in generating UB cells through anterior IM from mouse embry-
onic stem cells (mESCs) and human induced pluripotent stem
cells (hiPSCs). The induced mouse UB cells showed branching
morphogenesis and generated interconnection between NP-
derived nephrons and UB-derived collecting ducts. However,
the separate generation of metanephric NPs, mesonephric
NPs, and UB cells in in vitro differentiation culture systems or
the recapitulation of nephrogenesis-like physiological interac-
tions between metanephric NPs and UB cells that occur in em-
bryonic kidneys has not been fully investigated. Furthermore,
the reconstruction of kidney structures, in which separately
induced hPSC-derived metanephric NPs and UB cells are inter-
connected, has not been achieved.
In this study, we established a differentiation culture system
that provides a roadmap to inducing multiple progenitors consti-
tuting embryonic kidneys. Using this system, we recapitulated
nephrogenesis-like interactions between metanephric NPs and
UB cells, which subsequently generated glomeruli and intercon-
nected renal tubules and collecting ducts in vitro and in vivo.
RESULTS
Induction of hiPSCs into CDX1+ Cells Committed to
Mesoderm
The formation of the primitive streak (PS) is the first step inmeso-
derm development. To induce mesoderm from PSCs, we tested
various concentrations of a glycogen synthase kinase 3b (GSK-
3b) inhibitor, CHIR99021, which is a key regulator of mesoderm
induction, and monitored the expression of a PS marker,
BRACHYURY, on an hiPSC line, 585A1 (Evans et al., 2012;
Mendjan et al., 2014; Okita et al., 2013). Immunofluorescence
analysis showed that >3 mMCHIR99021 induced BRACHYURY+
PS cells (Figure 1A).
According to chick development, CDX1+ epiblast cells are
committed to mesodermal cells (Meyer and Gruss, 1993). We
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confirmed that treatment with 1 mM CHIR99021, 10 nM retinoic
acid (RA), 1 ng/mL bone morphogenetic protein (BMP) 4, and
100 ng/mL fibroblast growth factor (FGF) 2 induced hiPSCs to
differentiate into CDX1+ cells. These four factors had previously
been shown to relate to the expression of CDX1 in the epiblast
stage (Houle et al., 2003; Keenan et al., 2006; Lengerke et al.,
2008). We generated CDX1+ cells within 24 h of hiPSC differen-
tiation by activating the four signaling pathways (Figure 1B). As
expected, the induced CDX1+ cells also expressed a pluripotent
marker, OCT4, and an epithelial marker, CDH1, but not
BRACHYURY (Figure 1C), suggesting that the induced CDX1+
cells have epiblast-like characteristics.
Next, we evaluated the effects of adding the CDX1+ cell induc-
tion stage (stage 1) before the PS induction process on the
expression of mesodermal and endodermal markers. qRT-PCR
analyses showed that although PS induction protocols with or
without stage 1 successfully induced BRACHYURY+ PS cells,
the inclusion of stage 1 significantly downregulated the endo-
dermal genes FOXA2 and EOMES (Figure 1D). Therefore, the
addition of stage 1 prevented differentiation into endoderm-
committed PS. A previous study also showed that blocking
FGF signaling increased endodermal cell mass in amphibian an-
imal cap explants (Cha et al., 2004). We therefore addressed the
effects of adding FGF2 to the CHIR99021 treatment at the PS in-
duction stage (stage 2). We found that the activation of FGF
signaling blocked endoderm formation but maintained PS induc-
tion (Figure 1E). These results indicate that we established a pro-
tocol that induces hiPSCs through CDX1+ cells into mesoderm-
committed PS cells.
Induction of Lateral Plate Mesoderm
BMP signaling induces the formation of posterior PS and re-
presses anterior PS lineage, thus driving the bifurcation of these
two PS subtypes in vertebrates (Faial et al., 2015). In addition,
BMP7 is a main player among BMP signals in vertebrate PS for-
mation (Streit et al., 1998). We thus attempted to generate
PS subtypes by adding a BMP signaling gradient in the first
12 h of stage 2 (Figures 1F and 1G). CDX1+ cells treated with
25 ng/mL BMP7 (moderate concentration) for 12 h expressed
the posterior PS markers FOXF1 and HAND1 in addition to
BRACHYURY and MIXL1. Blocking BMP signaling by treatment
with 25 ng/mL NOGGIN abrogated PS induction (Figure 1G).
In vertebrate embryos, posterior PS gives rise to lateral plate
mesoderm (LPM) cells, and vascular endothelial cells (ECs) are
derived from an LPM subpopulation (Zhong et al., 2001). Previ-
ous studies have emphasized the critical role of BMP signaling
in the differentiation of hPSCs toward LPM cells (Iyer et al.,
2016; Mendjan et al., 2014). We thus prolonged the 25 ng/mL
BMP7 treatment at stage 2 and found that FLK1+ LPM cells
were generated at an induction rate of 96.8% ± 0.5% (n = 3)
on stage 2, day 3 (Figure S1A). We next aimed to drive these pro-
genitors toward ECs by using vascular specification media at
stage 3 (James et al., 2010; Nguyen et al., 2016). Because
WNT-b-catenin signaling induces endothelial mesenchymal
transformation and may inhibit EC formation (Kovacic et al.,
2012), we added IWR-1, an inhibitor of the WNT-b-catenin
pathway, to the directed differentiation protocol (Figure S1B).
Flow cytometric analysis of hiPSC-derived cells on stage 3,
day 4 showed that >90% of cells were vascular endothelial
(VE)-cadherin+. Consistently, both RT-PCR and immunofluores-
cence analyses showed that stage 3, day 4 cells without purifica-
tion expressed substantially higher levels of the EC markers
CD31 and eNOS (Figures S1C and S1D). Next, we carried out
a tube formation assay to confirm the angiogenic potential of
our hiPSC-derived ECs (Figure S1E). We confirmed the robust-
ness of our differentiation protocol on 4A6, which is an OSR1-
GFP/SIX2-tdTomato reporter hiPSC line generated from 201B7
(Figures S1F and S1G) (Mae et al., 2013; Toyohara et al.,
2015). We also confirmed that our differentiation protocol was
applicable under feeder-free cultures (Figure S1H). These results
Figure 1. Differentiation from hiPSCs through CDX1+ Epiblast-like Cells into LPM- and PAM-PS Cells
(A) Immunostaining analyses for BRACHYURY after 24 h treatment of hiPSCs with 0 (DMSO), 1, or 3 mM CHIR99021.
(B) qRT-PCR analysis of CDX1 expression after 24 h treatment of hiPSCs with various combinations of 4 factors. Each value was normalized to that of hiPSCs.
(C) Immunostaining analyses for OCT4, CDH1, CDX1, and BRACHYURY after 24 h treatment with the 4 factors.
(D) qRT-PCR analysis shows that the addition of the CDX1+ cell induction step (stage 1) significantly downregulates endodermal gene expression. Each value was
normalized to that of stage 2 cells treated without the CDX1+ stage.
(E) qRT-PCR analysis shows that the addition of FGF2 significantly downregulates endodermal gene expression. Each value was normalized to that of stage 2
cells without FGF2 treatment.(F) A simplified scheme of mesoderm induction and patterning defined by signaling gradients in distinct regions of PS.
(G) qRT-PCR analyses of mesodermal and endodermal gene expressions after treating CDX1+ cells for 24 h with the indicated concentrations of BMP7 or a BMP
inhibitor, NOGGIN, at the PS induction stage (stage 2). N25, 25 ng/mL NOGGIN; B7 1, 1 ng/mL BMP7; B7 25, 25 ng/mL BMP7. Each value was normalized to that
of stage 2 cells treated without any additional factors.
(H) Immunostaining analyses for BRACHYURY, TBX6, and CDX2 in CDX1+ cells treated with 3 mM CHIR99021 and 100 ng/mL FGF2 for 24 h and then with or
without 10 mM A83-01 for an additional 2 days.
(I) qRT-PCR analysis forCDX2 expression in CDX1+ cells treatedwith 3 mMCHIR99021 and 100 ng/mL FGF2 for 24 h and thenwith or without 10 mMA83-01 for an
additional 2 days. Each value was normalized to that of stage 3 cells without A83-01 treatment.
(J) A hypothetical scheme of mesoderm induction and patterning.
(K) Flow cytometric analyses of 4A6 treated with the indicated concentrations of BMP7 and NOGGIN at the PS and late-PS induction stages after an additional 3-
day culture without any inducing factors.
(L) Late PS cells treated with a low BMP7 expressed OSR1 (LPM-IM marker), while NOGGIN-treated late PS cells expressed PAX3 (PAM marker), after an
additional 3-day culture without any inducing factors.
(M) qRT-PCR analyses of marker expressions for sclerotome (SCL) and chondrogenic induction (Cl). Each value was normalized to that of sclerotome cells.
(N) Cartilage tissue differentiated from PAM through somitic mesoderm and sclerotome, as analyzed by Alcian blue staining.
*p < 0.05 and ***p < 0.001 by Student’s t test in (D) and (E). The data from 3 independent experiments are presented as themeans ±SEMs (n = 3) in (B), (D), (E), (G),
(I), and (M). Scale bars, 100 mm in (A), (C), (H), and (L) and 200 mm in (N).
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indicate that vascular ECs can be robustly generated by our dif-
ferentiation protocol through PS committed to LPMcells (Figures
S8A and S8B [i]).
Smad2/3 Inhibition after PS Induction Stage Induces
Late PS
Based on our qRT-PCR data (Figures 1F and 1G), we hypothe-
sized that the PS induction stage (stage 2) with or without low-
dose BMP (1 ng/mL) may induce paraxial mesoderm-committed
PS (PAM-PS) or IM-committed PS (IM-PS) cells. Previous
studies induced caudal PAM and NPs from hPSCs via BRA-
CHYURY+CDX2+ late PS cells (Mendjan et al., 2014; Morizane
et al., 2015; Taguchi et al., 2014; Takasato et al., 2015). Because
Smad2/3-related signals are crucial for repressing CDX2 expres-
sion in hPSC differentiation (Sakaki-Yumoto et al., 2013), we hy-
pothesized that an ALK5 inhibitor, A83-01, may facilitate CDX2+
late PS cell induction. To confirm this hypothesis, we induced
BRACHYURY+ PS cells from CDX1+ cells with CHIR99021 and
FGF2 for 12 h at stage 2 and then treated the cells with A83-01
(Figure 1H). At stage 3, the expressions of BRACHYURY,
TBX6, and CDX2, which represent a nascent posterior meso-
derm, were upregulated (Figures 1H and 1I). Therefore, our dif-
ferentiation protocol was able to induce late PS cells toward
caudal PAM and NPs.
Induction of PAM from Late PS Cells
Next, we aimed to induce PAM-PS and IM-PS cells from our late
PS cells. To monitor the induction of PAM-PS and IM-PS cells,
we used 4A6. We found that the PS induction stage (stage 2)
without BMP treatment reduced the induction of cells positive
for an IM-LPMmarker gene, OSR1, and the addition of NOGGIN
at the late PS induction stage (stage 3) further repressed the in-
duction (Figures 1J–1L). We investigated the expression of
OSR1, the LPMmarkerHAND1, and the PAMmarkers PARAXIS,
MEOX1, and PAX3 with various BMP signaling treatments at
stages 2 and 3 (Figure S1I). Treatments with moderate or low
concentrations of BMP7 at stages 2 and 3 upregulated the ex-
pressions of OSR1 and HAND1 or OSR1 alone, indicating that
the two treatments induced LPM and IM, respectively. Treat-
ment without BMP at stage 2 and with NOGGIN at stage 3
induced the expression of PAM marker genes (Figures 1L, S1J,
and S1K). We next examined the somitic lineage differentiation
capacity of the NOGGIN-treated late PS cells by using a sclero-
tome and cartilage induction protocol (Nakajima et al., 2018) and
found that the cells sequentially expressed markers for preso-
mitic and somitic mesoderm, sclerotome, and cartilage (Figures
1M, S1K, and S1L). The formation of cartilage tissue was
confirmed by Alcian blue staining (Figure 1N). These results sug-
gest that our method can induce late PS cells to PAM-PS cells
(Figures S8A and S8B [ii]).
Induction of Kidney Lineage Progenitors from Late PS
Cells
We found that adding a low concentration of BMP7 at stages 2
and 3 favors IM gene expression (Figures 1J–1L and S1I).
Next, we aimed to induce metanephric NPs from late PS cells
(Figure 2A). Since the activation of transforming growth factor
b (TGF-b) signaling through the Gdf11-activin receptor IIA and
IIB (AcrIIA, AcrIIB) enhances the transcriptional activation of
Hoxd11, which regulates the posterior specification for meta-
nephros development (Gaunt et al., 2013; Oh et al., 2002), we
examined whether activin A, an agonist of activin receptors,
inducedmetanephric NPs with HOXD11 expression. Immunocy-
tochemistry showed that exposing late PS cells to activin A
induced HOXD11 expression, indicating that activin A contrib-
uted to terminal patterning (Figure 2B). We then generated IM
by adding FGF9, RA, and a BMP signaling inhibitor, NOGGIN,
at stage 5, followed by inducing NPs with FGF9 and
CHIR99021 at stage 6 (Morizane et al., 2015; Taguchi et al.,
2014; Takasato et al., 2015) (Figure 2A). We confirmed the
expression of nephrogenic genes during stage 5 for IM induction
and further gene activation after stage 6 culture, producing
NP cells (Figure S2A). Our differentiation method generated
OSR1+SIX2+ cells at >85% induction efficiency from 4A6 (Fig-
ures 2C and 2D) and was also applicable to 585A1 maintained
on feeder cells (Figure S2B). Furthermore, ourmethodwas appli-
cable to feeder-free cultures by adjusting the concentration of
CHIR99021 from stages 2–4 and the duration of stage 2 (Fig-
ure S2C). Two additional hiPSC lines under feeder-free culture
conditions, 585A1 and CiRA00009, the latter of which is an
hiPSC line derived from a patient with autosomal dominant poly-
cystic kidney disease (Ameku et al., 2016), were efficiently
induced into SIX2+ cells at efficiencies of 76.1% ± 3.2% (n = 3)
and 69.2% ± 4.9% (n = 3), respectively (Figure S2D). These re-
sults were confirmed by qRT-PCR for SIX2 and CITED1
(Figure S2E).
Although SIX2+ cells induced without activin A treatment at
stage 4 exhibited low HOXD11 expression, we unexpectedly
observed that PS cells unexposed to activin A could differentiate
into cells expressing the NP markers OSR1 and SIX2 at an
Figure 2. Differentiation into Nephron Progenitor Cells and Formation of 3D Nephron Structures
(A) Differentiation protocol for HOXD11+ IM cells and NPs.
(B) Immunostaining analyses of BRACHYURY+HOXD11+ late PS cells on stage 4, day 3.
(C) Immunostaining analyses of NP-like cells induced with activin A treatment at stage 4 (Act(+)-NPs) on stage 6, day 3.
(D) Flow cytometric analysis of Act(+)-NPs for OSR1 and SIX2 expression on stage 6, day 3.
(E) Immunostaining analyses of NP-like cells induced without activin A treatment at stage 4 (Act()-NPs) on stage 6, day 3.
(F) Dot plots showing gene expressions in Act(+)- and Act()-NPs. Red dots show HOX cluster genes.
(G) Heatmap showing the expression levels of HOX cluster genes determined by RNA-seq.
(H) Bright-field (top panel) and immunofluorescence (bottom panel) images of aggregates formed from Act(+)-NPs after 10 days of air-liquid interface cultures.
CDH1, distal tubule marker cadherin 1 (green); LTL, proximal tubule marker Lotus tetragonolobus lectin (red); PODXL, podocyte marker podocalyxin (white).
(I and J) Whole-mount immunofluorescence analyses of day 10 nephron structures formed from Act(+)-NPs (I) and Act()-NPs (J) for markers of glomerular
podocytes and proximal and distal renal tubules.
Scale bars, 100 mm in (B), (C), (E), and (H) and 20 mm in (I) and (J).
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induction efficiency of 34.2% ± 2.5% (n = 3; Figures 2E, S2F, and
S2G). To address differences betweenNP-like cells inducedwith
and without activin A treatment (Act(+)-NP and Act()-NP,
respectively), we conducted RNA sequencing (RNA-seq).
Although the gene expression profiles of the two cell types
were similar, differentially expressed genes were detected
(Tables S1 and S2). In particular, we found a major difference
in the expression of HOX genes (Figures 2F and 2G); Act(+)-
NPs had a high expression of HOXD11, but Act()-NPs did not
upregulate posterior HOX genes (Figure 2G). Single-cell RNA-
seq analyses showed that both Act(+)-NP and Act()-NP popu-
lations were transcriptionally close to the NP population in gesta-
tional week (GW) 16 fetal human kidneys (Figure S3A; Lindstro¨m
et al., 2018b).
We then examined the developmental potential of Act(+)-NPs
to reconstitute 3D nephron-like structures in vitro by using a pre-
viously reported air-liquid interface culture method (Li et al.,
2016). Histological analysis showed nephron-constituting seg-
ments, including glomeruli and proximal and distal tubules,
contiguously connected to the nephron structures (Figures 2H
and 2I). Notably, reconstructed 3D organoids made from
Act()-NPs also developed glomeruli- andproximal anddistal tu-
bule-like structures (Figures 2J and S2H), but the expression of
two Henle’s loop markers, UMOD and NKCC2, was significantly
lower in the organoids derived from Act()-NPs than in those
from Act(+)-NPs (Figure S2I), implying that Act()-NPs were pro-
genitors of mesonephros, because mammalian mesonephros
lacks Henle’s loop (Wintour et al., 1996). AlthoughRNA-seq anal-
ysis did not show largedifferences in thegene expressionprofiles
between the twoorganoids (FigureS2J), hierarchical clusteringof
the gene expression profiles of the organoids generated from
Act(+)-NPs indicated similarity with the fetal human kidney of
the first and second trimesters of pregnancy (Figure S3B; Taka-
sato et al., 2015). Another study reported markers for mouse
mesonephros, including markers for early Henle’s loop (Georgas
et al., 2011). Consistently, our RNA-seq data showed the signifi-
cant upregulation of severalmesonephrosmarkers (TCN2,FBP1,
SLC27A2, and ENTPD5) and of early Henle’s loop (AADAC and
GPD1) in the organoids generated from Act()-NPs compared
with Act()-NPs (Figure S3C).
The different origins of mesonephros and metanephros occur
as distinct temporal sequences in the anterior-posterior axis
(Mugford et al., 2008; Taguchi et al., 2014). Our Act()-NPs
featured the expression of anterior HOX genes, whereas
HOXD11 expression was higher in Act(+)-NPs, further suggest-
ing that Act()-NP cells represent the anterior NP-like cells that
generate mesonephros (Figure 2G). In embryonic day (E) 11
mice, a higher expression of integrin a8 (Itga8) was reported in
mesenchymal cells throughout the nephrogenic cord, which
include mesonephric NPs, than in metanephric NPs (Figure S2K;
M€uller et al., 1997). Consistently, Act()-NPs had a higher
expression of ITGA8 than did Act(+)-NPs (Table S1). These
data suggest that Act(+)-NPs correspond to the metanephric
NPs of fetal kidney and that Act)-NPs are mesonephric NP-
like cells, indicating the successful induction of late PS and
IM-PS cells with developmental potential to differentiate into
these two NPs and the generation of 3D nephron-like structures
from hiPSCs (Figures S8A and S8B [iii], [iv]).
Finally, we attempted to generate UB lineages. We recently
established a directed differentiation protocol of UB cells from
hiPSCs bymimickingmammalian UBdevelopment in vivo, which
includes stepwise differentiation through anterior PS, anterior
IM, and Wolffian duct (WD) stages (Mae et al., 2018). We aimed
to modify the UB induction protocol by adding the CDX1+ cell
step and using the culture conditions established in this study.
Adding the CDX1+ cell step in advance of the anterior PS induc-
tion stage prevented differentiation to UB lineage (Figure S4A).
We instead found that branching UB structures were success-
fully generated from CDX1 cells in our culture system (Figures
S4B, S4C, S8A, and S8B [v]). These results suggest that UB cells
may have different origins at the epiblast stage frommetanephric
and mesonephric NPs.
hiPSC-Derived Metanephric NPs and UB Cells Interact
and Recapitulate Nephrogenesis In Vitro
Next, we aimed to reconstruct kidney structures from our hiPSC-
derived metanephric NPs and UB cells. For this purpose, we
used 201B7-derived hiPSC lines constitutively expressing GFP
(317-12) or mCherry (511-3E; Oceguera-Yanez et al., 2016)
and 2 hiPSC lines without fluorescent reporters (585A1 and
1231A3), which allowed us to distinguish the lineage of NP and
UB cell-derived tissues in co-culture experiments. We adopted
the in vitro organ culture system, in which culture media contain-
ing high concentrations of KnockOut Serum Replacement (KSR)
and plate agitation by a seesaw shaker were used to achieve
better survival of the cell aggregates (Przepiorski et al., 2018).
It was reported that in the mixed cultures of dissociated NPs
and UB cells from mouse embryos, UB cells first self-organize
by themselves and then start mutual interaction with NPs (Lefe-
vre et al., 2017). We accordingly dissociated and mixed the
hiPSC-derived NPs andUB cells to promote cell-to-cell contacts
and interactions (Figure 3A). Consistent with the findings of
mouse embryos, single UB cells from 1231A3 constructed
CALB1+ or CK8+ epithelia that were surrounded by 317-12-
derived GFP+SIX2+ or GFP+WT1+ NPs on day 4, which is remi-
niscent of nephrogenic niches in mouse embryos (Figures 3B
and S5A). This result was reproduced in tdTomato+ NPs differen-
tiated from 4A6- and 1231A3-derived UB cells (Figure 3C). A
recent study investigating human embryonic kidneys indicated
transcription factor SIX1 as a specificmarker for humanNPs dur-
ing active nephrogenesis (Lindstro¨m et al., 2018b). Another
report demonstrated that LEF1+ NPs exist near the ureteric tip
and develop pre-tubular aggregates and renal vesicles in hu-
mans, and that the connecting and distal segments of
human S-shaped bodies are JAGGED1HNF1B+, while the
medial and proximal segments are JAGGED1+HNF1B+ (Lind-
stro¨m et al., 2018c). As expected, GFP+SIX1+ and GFP+SALL1+
cells constituted cap mesenchyme-like structures localized near
CALB1+RET+ UB tip-like structures, and GFP+LEF1+ cells were
localized near UB tip- and renal vesicle-like structures in the
co-culture of 317-12-derived NPs and 585A1 or 1231A3-derived
UB cells on day 6 (Figures 3D and S5B). We also found that the
distal parts of GFP+BRN1+ and GFP+HNF1B+ S-shaped body-
like structures, whose proximal or medial parts were JAGGED1+,
were connected to CALB1+ or CK8+ UB tip-like structures (Fig-
ures 3E and S5C). GFP+MAFB+ podocyte progenitors were
6 Cell Reports 31, 107476, April 7, 2020
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observed at the proximal end of the S-shaped body-like struc-
tures (Figure 3E).
In embryonic kidneys, UB cells secrete Wnt11 in response to
glial cell-derived neurotrophic factor (GDNF) secreted by NPs
and maintain the expression of Ret and its downstream targets,
Etv4 and Etv5 (Lu et al., 2009). In mice, Elf3 is expressed in col-
lecting duct principal cells and increases the expression of Aqp2
and Avpr2 (Grassmeyer et al., 2017). We thus generated kidney
organoids from 317-12-derived NPs and 511-3E-derived UB
cells and examined the expression of the aforementioned mole-
cules in UB cells isolated by flow cytometry on day 10 (Figures
S5D–S5G). As expected, the expression of RET and of markers
for the UB trunk (WNT7B and TACSTD2) was maintained, while
the expression of ETV4 and ETV5 and of markers for the collect-
ing duct (AVPR2,AQP3,KLF5, ELF3, andATP6V1B1) was signif-
icantly upregulated in UB-derived cells upon co-culture
compared with before co-culture or culture without NPs for
10 days (Figures S4B and S5D–S5G; Table S3; Wang et al.,
2018). Furthermore, the co-culture of hiPSC-derived NPs and
UB cells resulted in differentiation into kidney structures, while
the culture of hiPSC-derived NPs alone did not (Figures S5H
and S5I). These results suggest that our hiPSC-derived meta-
nephric NPs and UB cells approximately show the reciprocal in-
teractions seen by their counterparts in embryonic kidneys.
hiPSC-Derived Metanephric NPs and UB Cells
Reconstruct Interconnected Kidney Structures In Vitro
By culture day 20, the organoids from 317-12-derived GFP+ NPs
and 1231A3-derived UB cells developed kidney structures con-
taining PODXL+ podocytes, LTL+ proximal tubules, CDH1+ or
AVPR2+ distal tubules and collecting ducts, and CALB1+ collect-
ing ducts (Figure 3F). We then examined epithelial connections in
the organoids generated from 317-12-derived GFP+ NPs and
511-3E-derived mCherry+ UB cells and confirmed connections
between GFP+ tubular structures and mCherry+ ductal struc-
tures by counterstaining with anti-CDH1, anti-GATA3, and anti-
CK8 antibodies (Figures 3G and S6A). The connecting sites
were positive for markers of distal tubules or collecting ducts
(AQP2, AQP3, AQP4, PAX8, AVPR2, HNF1B, SOX9, and CK19)
and for a marker of collecting ducts (CALB1) in the organoids
from 317-12-derived GFP+ NPs and 585A1- or 1231A3-derived
UB cells, which is consistent with embryonic kidneys (Figures
S6B–S6D; Harding et al., 2011; Lindstro¨m et al., 2018c). In the or-
ganoids, markers of glomerular podocytes (NEPHRIN, WT1, and
PODXL; Figure 3H), proximal tubules (LTL, AQP1, SGLT2, JAG-
GED1, and CDH6; Figures 3H, 3I, and S6E), Henle’s loop
(UMOD, NKCC2, and BRN1; Figures 3J and S6F), and distal
tubules (BRN1 and DBA; Figure 3J) were expressed in GFP+
NP-derived structures. In contrast, we found GFPGATA3+ col-
lecting duct cells double positive for several principal cell
markers (AQP2, AQP3, and AQP4) and two intercalated cell
markers (PENDRIN and ATP6V1B1; Figures 3K and S6G; Chen
et al., 2017). Unlike mice, human collecting ducts, but not distal
tubules express CALB1 in GW8–11 developing kidneys (Lind-
stro¨m et al., 2018a). We also confirmed in GW28 human embry-
onic kidneys that only collecting ducts express CALB1, while
both distal tubules and collecting ducts are positive for AQP2,
AQP3, AQP4, BRN1, GATA3, CDH1, and DBA (Figures S7A–
S7D). Consistently, while we did not detect CALB1 in tubules
derived from GFP+ metanephric NPs (Figures 3B–3D, S6C, and
S6G), we found GFP+ distal tubules positive for AQP2, AQP3,
AQP4, BRN1, GATA3, CDH1, or DBA (Figures 3G, 3J, 3K,
S6B–S6D, and S6G). These data suggest that hiPSC-derived
NPs and UB cells reconstructed the kidney structures with inter-
connected renal tubules and collecting ducts in vitro.
hiPSC-Derived Metanephric NPs and UB Cells
Reconstruct Interconnected and Vascularized Kidney
Structures In Vivo
Finally, we transplanted mixed cellular aggregates of 317-12-
derived GFP+ NPs and 585A1- or 1231A3-derived UB cells under
the kidney capsule of immunodeficient mice, as previously
Figure 3. In Vitro Reconstruction of Kidney Structures from Induced Metanephric NPs and UB Cells
(A) Schematic showing the in vitro reconstruction of kidney structures.
(B) Immunofluorescence analyses for SIX2 (NPmarker) and CALB1 (UBmarker) on amixed aggregate of metanephric GFP+NP andGFPUB cells on day 4 of the
co-culture.
(C) Immunofluorescence analyses for tdTomato, GFP, and CALB1 on amixed aggregate of metanephric NPs differentiated from 4A6 and GFPUB cells on day 4
of the co-culture.
(D) Immunofluorescence analyses of day 6 organoids fromGFP+ NPs and GFPUB cells show that the GFPCALB1+RET+ UB tip-like structure connected to the
GFP+ NP-derived structure (top panels) and that the GFP+SIX1+ cap mesenchyme-like structure (middle panels) and the GFP+LEF1+ NPs localized near
GFPCALB1+ UB tip-like structures (bottom panels).
(E) Immunofluorescence analyses of day 6 organoids from GFP+ NPs and GFP UB cells show that GFP+ S-shaped body-like structures, whose proximal or
medial parts were JAGGED1+, connected to GFPCK8+ UB tip-like structures (top panels) and that MAFB+ podocyte progenitors localized at the proximal end of
GFP+ S-shaped body-like structures, whose medial and distal parts were BRN1+ (bottom panels).
(F) Triple immunofluorescence analyses of day 20 organoids for markers of podocytes (PODXL), proximal tubules (LTL), and distal tubules or collecting ducts
(CDH1; top panel), and for PODXL and markers of distal tubules or collecting ducts (AVPR2) and colleting ducts (CALB1; bottom panel). Note that weak CDH1
signals were also found in parts of the LTL+ proximal tubules in the top panel.
(G) Immunofluorescence analyses of day 10 organoids derived from GFP+ NPs and UB cells differentiated from hiPSCs constitutively expressing mCherry for
markers of distal tubules or colleting ducts (CDH1 and GATA3).
(H–J) Immunofluorescence analyses of days 10–20 organoids derived from GFP+ NPs and GFP UB cells for markers of glomerular podocytes (NEPHRIN, WT1,
and PODXL; H), proximal tubules (LTL, AQP1, SGLT2, and JAGGED1; H and I), Henle’s loop (UMOD, NKCC2, and BRN1; J), and distal tubules (BRN1 andDBA; J).
(K) Immunofluorescence analyses of day 20 organoids derived from GFP+ NPs and GFP UB cells show GFPAQP2+GATA3+, GFPAQP3+GATA3+, and
GFPAQP4+GATA3+ principal cells and GFPPENDRIN+GATA3+ and GFPATP6V1B1+GATA3+ intercalated cells of collecting ducts. Note that
GFP+AQP2+GATA3, GFP+AQP4+GATA3, and GFP+PENDRIN+GATA3+ distal tubules were also found.
Scale bars, 100 mm in (B), (E), and (F) and 20 mm in (C), (D), and (G)–(K).
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reported (Figures 4A, S7E, and S7F; Bantounas et al., 2018; Shar-
min et al., 2016). As expected, the resultant kidney organoids
20 days after transplantation were vascularized by host ECs, as
evidenced by positive anti-mouse CD31 staining, and the ECs in-
tegrated into human glomerulus-like structures with parietal
epithelia of Bowman’s capsule in the organoids (Figures 4B, 4C,
and S7G). To address whether the vascularized network was
functional, we observed the transplanted kidney organoids
10 days after transplantation by intravital imaging using multi-
photon microscopy. After tail vein injections of rhodamine B-con-
jugated dextran, we identified vessel lumens penetrating into the
hiPSC-derived glomerulus-like structures (Figures 4D, white ar-
rows, and S7H; Video S1). We then examined epithelial connec-
tions in the organoids generated from 317-12-derived GFP+
NPs and 511-3E-derived mCherry+ UB cells and confirmed con-
nections between GFP+ tubular structures and mCherry+ ductal
structures, which were counterstained with anti-AVPR2 and
anti-CDH1antibodies (Figure 4E).Wealso found that the epithelial
connecting points were positive for a marker of distal tubules or
collecting ducts, AQP3, in organoids generated from 317-12-
derived GFP+ NPs and 1231A3-derived UB cells (Figure 4F).
The organoids also contained GFP+PODXL+WT1+ glomerulus
(Figure 4G), GFP+LTL+JAGGED1+ proximal tubule (Figures
4Hand S7I), GFP+ UMOD+BRN1+ Henle’s loop (Figure 4I), and
GFPCALB1+AVPR2+ (Figure 4J) and GFPCDH1+AQP2+ col-
lecting duct structures (Figure 4K) and showed the interconnec-
tion of Bowman’s space and the luminal space of proximal tu-
bules (Figure 4L). These results suggest that hiPSC-derived
singleNPs andUBcells developed vascularized kidney structures
with interconnections between the renal tubules and collecting
ducts in vivo.
DISCUSSION
Although previous studies induced CDX2+ late PS cells toward
NPs by treatment with CHIR99021 (Morizane et al., 2015; Tagu-
chi et al., 2014; Takasato et al., 2015), the high concentration
used may cause adverse effects, including cytotoxicity and un-
stable cell differentiation (Naujok et al., 2014). We instead suc-
ceeded in robustly and stably generating CDX2+ late PS cells
by adding Smad2/3 inhibitors after the PS induction stage
without a high dose of GSK3 inhibitors. Recently, Loh et al.
(2016) reported methods to induce mesoderm lineages, except
for IM from hPSCs. In the present study, we succeeded in estab-
lishing an equally efficient method to induce LPM and PAM cells.
Moreover, we could generate multiple IM-lineage cells in our
systematic differentiation map.
The separate induction of metanephric and mesonephric NPs
and UB cells in in vitro monolayer culture systems has not been
fully investigated. RNA-seq analyses in this study showed that
Act(+)-NPs strongly expressed HOXD11, whereas Act()-NPs
did not upregulate posterior HOX cluster genes. In addition, a
higher expression of ITGA8 was found in Act()-NPs compared
with Act(+)-NPs, which may correlate with the higher Itga8
expression reported in mesonephric NPs compared with meta-
nephric NPs in mouse embryos (Figure S2K; M€uller et al.,
1997). The analyses also showed that ROBO2 and FAT4 expres-
sion is significantly higher in Act(+)-NPs than in Act()-NPs (Ta-
ble S2). It was reported that higher ROBO2 expression in MM
negatively regulates the number of UB outgrowths from the
nephric duct (Grieshammer et al., 2004; Wainwright et al.,
2015) and that the number of outgrowths from the nephric duct
in mesonephros is larger than in metanephros (Clapp, 2017).
Another recent study reported that Fat4 mutant mice have
ectopic UB formation and identified Fat4 as a regulator of
ureteric budding and excessive RET signaling (Zhang et al.,
2019). Therefore, our data are consistent with previous findings
and indicate that a higher expression of ROBO2 and FAT4 in
metanephric NPs than in mesonephric NPs leads to less
outgrowth from the nephric duct in metanephros than in
mesonephros.
In addition, the expression of two Henle’s loop markers,
NKCC2 and UMOD, was higher in organoids derived from
Act(+)-NPs than from Act()-NPs, which is consistent with the
finding that mammalian mesonephros lacks Henle’s loop (Win-
tour et al., 1996). However, another study reported that marker
genes for early Henle’s loop are expressed in mouse meso-
nephros (Georgas et al., 2011). Our RNA-seq analysis showed
that the expression of mesonephric nephron markers (TCN2,
FBP1, SLC27A2, and ENTPD5) and of early Henle’s loop
(AADAC and GPD1) was significantly upregulated in Act()-or-
ganoids compared with Act()-NPs, which is consistent with
Figure 4. In Vivo Reconstruction of Vascularized Kidney Structures from Induced Metanephric NPs and UB Cells
(A) Schematic showing the in vivo reconstruction of kidney structures.
(B) A lower magnification image of DBA staining of the human kidney graft generated from GFP+ NPs and GFP UB cells and host mouse kidney 20 days after
transplantation. The right panel is a magnified image of the boxed area. Note that DBA+ cells were found in the collecting ducts of the host mouse kidney and
human kidney graft and that weak signals were also found in the distal tubules.
(C) Immunofluorescence analyses of NEPHRIN and mouse CD31 in glomerulus-like structures in the human kidney grafts 20 days after transplantation.
(D) Intra-vital 2-photon laser-scanning microscopic images of the human kidney graft from GFP+ NPs and UB cells differentiated from hiPSCs constitutively
expressingmCherry (mCherry+ UB cells) before and after rhodamine B-conjugated dextran injection. The white arrows indicate vessel lumens penetrating into an
hiPSC-derived glomerulus-like structure, as evidenced by rhodamine B fluorescence. Note that no mCherry+ cells were observed in the areas before the dextran
injection.
(E) Immunofluorescence analyses of markers for distal tubules or collecting ducts (AVPR2 and CDH1) show GFP+ NP-derived distal tubules connected to
mCherry+ UB cell-derived collecting ducts.
(F) Immunofluorescence analyses of a distal tubule or collecting duct marker (AQP3) and PAX8 showGFP+ NP-derived distal tubules connected to GFPUB cell-
derived collecting ducts.
(G–L) Immunofluorescence analyses of the kidney grafts generated from GFP+ NPs and GFP UB cells show GFP+PODXL+WT1+ glomerulus (G),
GFP+LTL+JAGGED1+ proximal tubule (H), GFP+UMOD+BRN1+ Henle’s loop (I), GFPCALB1+AVPR2+ (J), and GFPCDH1+AQP2+ collecting ducts (K), and
GFP+PODXL+ glomerulus and GFP+LTL+ proximal tubule (L). Note that Bowman’s space is interconnected with the luminal space of the proximal tubule in (L).
Scale bars, 200 mm in (B) and 20 mm in (C)–(L).
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Georgas et al. (2011). Since confirming the similarity of our
Act()-NPs with mesonephric NPs in human embryos is difficult
due to limited embryo samples, we called our Act()-NPs meso-
nephric NP-like cells. Taken together with previous findings, our
data indicate that mesonephric nephron contains cells that ex-
press markers for early Henle’s loop, but not late or mature
Henle’s loop. Future studies should further characterize our
Act()-NPs by comparing them to their counterparts in human
embryos. Nonetheless, we established a differentiation system
that can separately induce metanephric NPs and mesonephric
NP-like cells as well as UB cells from hiPSCs, which should
contribute to disclosing the developmental mechanisms of hu-
man kidneys.
Harari-Steinberget al. (2013) identified committedNPs fromhu-
man fetal kidneyby culturing in serum-free definedconditions and
prospective isolation by using NCAM1. The NP population
showed clonogenic capacity, in vivo nephrogenic capability
when grafted on the chick embryos, and therapeutic benefits in
a mouse model of chronic progressive renal injury that mimics
chronic kidney disease (CKD) in humans. AlthoughNCAM1+ pop-
ulations contain both SIX2+ and SIX2 progenitors in human fetal
kidney, the group later showed that the NCAM1+CD133 fraction
more efficiently concentrates SIX2+ NPs (Pode-Shakked et al.,
2016). Furthermore, they dissected NCAM1+CD133 progenitors
according to epithelial cell adhesion molecule (EpCAM) expres-
sion by culturing in a defined medium modified from a previously
reported NP expansion medium (Brown et al., 2015) and showed
that theNCAM1+CD133EpCAM fractioncontainsacapmesen-
chyme population that overexpresses SIX2,WT1,OSR1, CITED1,
EYA1, SIX1, and CDH11 (Pode-Shakked et al., 2017). The hiPSC-
derivedmetanephricNPs thatwegenerated are close to that pop-
ulation in terms of the expression of the aforementioned markers
evaluated by RNA-seq (data not shown) and nephrogenic poten-
tial in vitro and in vivo. Further comparisons of hiPSC-derived
NPs with NCAM1+CD133EpCAM cells in the human fetal kid-
ney, including functional comparisons, would contribute to the
stable generation of genuine NPs from hiPSCs.
The present study also shows reciprocal interactions between
NPs and UB cells in nephrogenic niches and the generation of
human kidney organoids that contain collecting ducts that ex-
press multiple collecting duct lineage markers (CALB1, AQP2,
AQP3, AQP4, AVPR2, PENDRIN, and ATP6V1B1), in addition
to glomeruli and renal tubules. Moreover, our reconstructed
kidney organoids showed nephron-constituting segments,
including glomeruli, proximal and distal tubules, and Henle’s
loop, which contiguously connected to the collecting duct struc-
tures that differentiated from hiPSCs. Therefore, our differentia-
tion system could contribute to understanding the mechanisms
of the reciprocal interactions and interconnections between
NP-derived tubules and UB-derived collecting ducts in humans.
Finally, one report implanted hiPSC-derived NP aggregates
into the renal subcapsules of immunodeficient mice to generate
vascularized glomeruli-like structures in vivo (Sharmin et al.,
2016). Other studies generated vascularized kidney organoids
by implanting hPSC-derived kidney lineage aggregates contain-
ing simultaneously induced NP- and UB-lineage cells using a dif-
ferentiation protocol similar to Takasato et al. (2015) into immu-
nodeficient mice subcutaneously (Bantounas et al., 2018; van
den Berg et al., 2018). In the present study, we successfully vas-
cularized kidney organoids generated from separately induced
hiPSC-derived NPs and UB cells in vivo, in which the nephron
structures differentiated from hiPSC-derived metanephric NPs
contiguously connect to collecting duct structures derived
from hiPSC-derived UB cells in the organoids. Dekel et al.
(2003) found that the transplantation of human and porcine
metanephric kidney precursor tissues only at optimal develop-
mental time points (7–8 weeks of human gestation or 3.5–
4 weeks of pig gestation) into mice survive, grow, differentiate
into nephrons with a robust formation of vascularized glomeruli
and tubules, and form a functional kidney organ that produces
dilute urine. They also demonstrated decreased immunogenicity
of the transplants of early human and pig kidney precursors
compared with adult kidney transplants. However, our hiPSC-
derived kidney grafts developed less vascularized glomeruli
and did not form cyst structures containing urine (Figure 4B).
Future studies should examine the optimal differentiation stages
of hiPSC-derived kidney progenitors for transplantation so that
the resultant grafts frequently develop functional nephrons with
vascularized glomeruli that are suitable for transplantation in hu-
mans with less immunogenicity compared with adult kidneys
presently used in renal transplantation.
In summary, we established stepwise differentiation protocols
for the three main kidney progenitor cells and LPM and PAM in
a monolayer culture system. Our system reproduces multiple
developmental steps with stage-specific gene expressions accu-
rately. Moreover, it can generate vascularized interconnected kid-
ney organoids from the induced progenitors. However, some lim-
itations must be overcome. We did not achieve the extensive
branching morphogenesis of UBs. Future studies should estab-
lish the induction protocol of renal stromal cells, because these
cell types may contribute to the UB branching capacity (Taguchi
and Nishinakamura, 2017). We should also improve glomerular,
tubular, and ductal functionalmaturity. Nevertheless, the differen-
tiation protocols and kidney reconstruction methods established
in this study may contribute to understanding the mechanisms
underlying human kidney development and congenital renal dis-
orders as well as the mechanisms generating suitable transplant-
able cells for regenerative therapies.
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Kenji
Osafune (email: osafu@cira.kyoto-u.ac.jp). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Tissues
Frozen section slides of GW28 human fatal kidney and human adult kidney (78 years old male) were purchased from US Biomax Inc.
and BioChain, respectively.
Mice
The KyotoUniversity Animal Care Committee approved all animal experiments. No formal randomization was performed in this study.
Male 5-15 weeks old NOD.CB17-Prkdcscid/J mice were purchased from Oriental bioservice, Inc. All mice were housed at the lab-
oratory animal facility of the Center for iPS Cell Research and Application (CiRA), Kyoto University, under specific pathogen-free
(SPF) conditions. The room has controlled temperature (21-25C), humidity (45%–55%) and light (12-hours light-dark cycle). Mice
were provided ad libitum access to food and water.
hiPSC Line and Maintenance
Experiments using hiPSCs were approved by the Ethics Committee of Kyoto University, and informed consent was obtained from
donors from whom hiPSCs were derived. Two hiPSC lines, 4A6 and 585A1, were maintained on mitomycin C-treated mouse SNL
cells in Primate ES medium (ReproCELL) supplemented with 4 ng/ml recombinant human basic fibroblast growth factor (bFGF;
Wako) and 500 U/ml penicillin/streptomycin (PS; Thermo Fisher Scientific). For routine passaging, hiPSCs were washed once with
phosphate buffered saline (PBS, Nacalai Tesque) and then incubated with CTK dissociation solution containing 0.1% collagenase
IV (Thermo Fisher Scientific), 0.25% trypsin (Thermo Fisher Scientific), 20% knockout serum replacement (KSR; Thermo Fisher Sci-
entific) and 1 mM CaCl2 in PBS. The split ratio was between 1:3 and 1:6. hiPSC lines constitutively expressing GFP (317-12) or
mCherry (511-3E) along with three other hiPSC lines, 1231A3, 585A1 and CiRA00009, were maintained with feeder-free cultures us-
ing Stem Fit AK02Nmedium (Takara) on cell culture plates coatedwith iMatrix-511 silk (Nippi). The cells were passaged using 0.5mM
EDTA/PBS (Thermo Fisher Scientific) every four days. hiPSCs were routinely examined for mycoplasma contamination.
Continued
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Slc:ICR SHIMIZU Laboratory Supplies
Co., Ltd
Jackson Laboratory: Stock No: 009122
Oligonucleotides
Primers for Figures 1, S1, S2, and S5; Table S4 This paper N/A
Software and Algorithms
BZ-X Analyzer KEYENCE BZX700
CASAVA 1.8.2 Institut Pasteur http://bioweb.pasteur.fr/packages/
pack@casava@1.8.2
Cell Ranger v2.1.0 pipeline 10X Genomics https://support.10xgenomics.com/
FACS Diva BD FACSDiva v8.0.1 Software
FlowJo BD FlowJo v10
ImageJ 1.51u Schneider et al., 2012 https://imagej.nih.gov/ij/
Microsoft Excel 2013 https://products.office.com/home Microsoft Office Standard 2013
NIS-Elements AR Nikon NIS-Elements AR Ver4.20.00
NIS-Elements Viewer Nikon NIS-Elements Viewer Ver. 4.0
R The R Foundation R version 3.4.1. or 3.5.2
RPKMforGenes Sandberg Laboratory http://sandberg.cmb.ki.se/media/data/rnaseq/
instructions-rpkmforgenes.html
RStudio RStudio, Inc. RStudio Version 1.1.463
Tophat v2.0.14 Johns Hopkins University https://ccb.jhu.edu/software/tophat/index.shtml
ZEN 2 blue edition ZEISS ZEN 2.3 (blue edition)
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METHOD DETAILS
Differentiation Protocols
hiPSC colonies grown on SNL feeder cells were first treated by an enzymatic method with CTK dissociation solution for 3 min to re-
move SNL cells, dissociated into single cells by gentle pipetting after treatment with Accutase (Innovative Cell Technologies) for 6min
and seeded on Matrigel (Matrigel Matrix Growth Factor Reduced, BD)-coated 24-well plates (CORNING) at a density of 2.5 3 104
cells/cm2 with Primate Repro FF2 medium (ReproCELL), 4 ng/ml bFGF, 10 mMY-27632 and 500 U/ml PS. On culture day 2, the cells
were treated in serum-free differentiation medium consisting of DMEM/F12 Glutamax medium (Thermo Fisher Scientific), B27 sup-
plement minus vitamin A (Thermo Fisher Scientific), and 500 U/ml PS (hereafter called basal medium) supplemented with 1 mM
CHIR99021 (StemRD), 10 nM RA (SIGMA), 1 ng/ml BMP4 (Peprotech) and 100 ng/ml bFGF to induce CDX1+ cells.
LPM and vascular cell induction
For differentiation toward LPM and vascular cells, CDX1+ cells were cultured with 3 mM CHIR99021, 100 ng/ml bFGF and 25 ng/ml
BMP7 for 3 days. Then, the cells were dissociated with Accutase and replaced on Laminin 411 (BioLamina)-coated 24-well plates in
StemPro-34 SFM (Thermo Fisher Scientific) supplemented with 50 ng/ml recombinant human VEGF (Peprotech), 10 ng/ml bFGF,
10 mM DAPT (R&D Systems), 20 ng/ml BMP4 and 10 mM IWR1 (SIGMA) for 4 days.
PAM and sclerotome induction
For differentiation toward PAM and sclerotome, CDX1+ cells were cultured with 3 mMCHIR99021 and 100 ng/ml bFGF. After 12 h, the
medium was switched to basal medium containing 3 mM CHIR99021, 100 ng/ml bFGF, 25 ng/ml NOGGIN and 10 mM A83-01 to
induce PAM-PS cells. Detailed procedures of the differentiation into PAM and sclerotome were previously described (Nakajima
et al., 2018).
IM and metanephric nephron progenitor (NP) induction
For differentiation toward IM andNP cells, CDX1+ cells were culturedwith 3 mMCHIR99021, 100 ng/ml bFGF and 1 ng/ml BMP7 (R&D
Systems). After 12 h, the medium was switched to basal medium containing 3 mM CHIR99021, 100 ng/ml bFGF, 1 ng/ml BMP7 and
10 mMA83-01 (Wako). At Stage 4, the medium was changed to basal medium containing 3 mMCHIR99021, 100 ng/ml bFGF, 1 ng/ml
BMP7, 10 ng/ml activin A (R&D Systems) and 30 mM Y-27632 (Wako). At Stage 5, the medium was changed to basal medium con-
taining 200 ng/ml FGF9 (Peprotech), 0.1 mM RA and 25 ng/ml NOGGIN (Peprotech). At Stage 6, the medium was switched to basal
medium containing 200 ng/ml FGF9 and 1 mM CHIR99021. Subsequently, the culture medium was refreshed every day.
Mesonephric NP-like cell induction
The same protocol as the metanephric NP induction described above was used except for removing activin A at Stage 4.
UB induction
UB lineages were induced by modifying a previously reported protocol (Mae et al., 2018). Briefly, hiPSCs were treated with basal
medium containing 100 ng/ml activin A, 3 mM CHIR99021 and 10 ng/ml BMP4 for 24 h to induce anterior PS cells. At stage 2, the
medium was changed to basal medium containing 200 ng/ml FGF8 (Peprotech), 0.1 mM 4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetra-
methyl-2-naphthalenyl)-1-propenyl]-benzoic acid (TTNPB; Santa Cruz Biotechnology), 1 mM A83-01 and 0.1 mM LDN193189 for
3 days. Thereafter, anterior IM cells were treated with basal medium containing 1 mM CHIR99021, 0.1 mM LDN193189, 200 ng/ml
FGF8 and 100 ng/ml glial cell line-derived neurotrophic factor (GDNF; R&D Systems) for 2 days to enhance WD leading edge cell
induction. Then, the cells were reseeded onto low-attachment 96-well plates (Sumitomo Bakelite) at a density of 1 3 104 cells/
well in basal mediumwith 100 ng/ml GDNF, 200 ng/ml FGF1 (R&D Systems), 0.1 mMTTNPB, 3 mMCHIR99021 and 10 mMThiazovivin
(Santa Cruz Biotechnology) to induce mature WD aggregates for 2 days. The mature WD aggregates were embedded into 30 mL
Matrigel (BD Biosciences) diluted with Essential 6 medium (1:1; Thermo Fisher Scientific) in low-attachment 96-well plates and incu-
bated for 30min. After the solidification ofMatrigel, Essential 6medium supplementedwith 100 ng/ml GDNF, 200 ng/ml FGF1, 0.1 mM
TTNPB, 3 mM CHIR99021 and 10 mM Thiazovivin was added.
Immunostaining
The cells were fixed with 4% PFA/PBS at 4C for 15 min after a brief wash with PBS. Fixed cells were washed with PBS and then
blocked with PBST (PBS/0.4% Triton X-100)/5% normal donkey serum (Jackson ImmunoResearch Laboratories, JIRL) for 1 h at
room temperature. Whole-mount immunostaining was performed as described previously (Li et al., 2016). In brief, primary antibodies
were diluted in blocking solution and incubated with the fixed cells for 3 h at room temperature. After wash with PBST, secondary
antibodies were incubated for 30 min at room temperature.
Frozen human embryonic kidney sections (GW28) and human adult kidney sections (78 years old male) were purchased from
Biomax and BioChain, respectively. Section immunostaining was started by washing with PBS. Then, the sections were blocked
with PBST/5% normal donkey serum for 1 h at room temperature. Primary antibodies were diluted in blocking solution and incubated
with the sections for 24 h at 4C. After wash with PBST, secondary antibodies were incubated for 2 h at 4C. Information about the
antibodies used in this study is shown in Table S3.
Fluorescent images of the reconstructed kidney structures were captured by BZ-X700 (KEYENCE), multiphoton microscopy
(Nikon A1R MP) or confocal microscopy (Zeiss LSM710). Image analysis was performed using BZ-X Analyzer (KEYENCE), ZEN 2
blue edition (Zeiss), NIS-Elements Viewer 4.0 (Nikon) or ImageJ version 1.51j8.
Cell Reports 31, 107476, April 7, 2020 e5
Flow Cytometry and Cell Sorting
The cells were incubated with Accumax (Innovative Cell Technologies) for 5 min at 37C and dissociated by pipetting. Dead cells
stained with 4’,6-diamidino-2-phenylindole, dihydrochloride (DAPI; 0.1 ng/ml; Thermo Fisher Scientific) were excluded from the an-
alyses. The cells were analyzed and sorted using a FACS Aria II cell sorter (BD). For vascular ECs, anti-FLK1 antibody (359910, Bio-
Legend) and anti-VE-cadherin monoclonal antibody (560410, BD PharMingen) was used at 1:10 and 1:20, respectively. The isolated
cells were collected into basal medium containing 10 mMY-27632. The data were analyzed using the FlowJo or FACS Diva (BD) soft-
ware programs.
RT-PCR and Real-time Quantitative RT-PCR (qRT-PCR)
Total RNA was isolated using the RNeasy Kit (QIAGEN) according to the manufacturer’s recommendations, followed by cDNA syn-
thesis using standard protocols. Briefly, 1 mg of total RNA was treated with DNase I (QIAGEN) for 15 min, and the cDNA was synthe-
sized using ReverTra Ace (TOYOBO) or Superscript III reverse transcriptase (Thermo Fisher Scientific). The cDNA samples were sub-
jected to PCR amplification using a thermal cycler (Veriti 96-well Thermal Cycler; Thermo Fisher Scientific). PCRwas performed using
the Ex-Taq PCR Kit (Takara) according to the manufacturer’s instructions. The PCR cycles were as follows. For b-ACTIN, the initial
denaturation was performed at 94C for 2.5 min, followed by 25 cycles of 94C for 30 s, 60C for 1 min, 72C for 30 s and a final
extension at 72C for 10 min. For all other genes, the cycles consisted of an initial denaturation at 94C for 2.5 min, 30-40 cycles
of 94C for 30 s, 58-62C for 30 s, 72C for 30 s and a final extension at 72C for 7 min. qPCR was performed using the Step One
Plus Real-Time PCR System (Thermo Fisher Scientific) and SYBR Green PCR Master Mix (Takara) or using the QuantStudio 12K
Flex real-time PCR system (Thermo Fisher Scientific) and Thunderbird SYBR qPCR Mix (TOYOBO). Denaturation was performed
at 95C for 10 min, followed by 45 cycles at 95C for 5 s and at 60C for 30 s. As recommended by the manufacturer, the threshold
cycle method was used to analyze the data for the gene expression levels and normalized to those of the housekeeping gene,
b-ACTIN. The PCR reactions were performed in triplicate for each sample. The primer sequences are listed in Table S4.
Tube Formation Assay
The tube formation assay was performed as described previously (Homma et al., 2010). In brief, vascular endothelia derived from
hiPSCswere seeded ontoMatrigel-coated 24-well plates at 4.03 104 cells/well. The cells were incubated for 24 h, and digital images
of the tube formation were captured.
Alcian Blue Staining
Cells were fixed with 4% PFA/PBS for 30 min at room temperature, rinsed with PBS and stained overnight with Alcian Blue solution
(1% Alcian Blue, pH1; Muto Pure Chemicals).
Organ Culture
Nephron organoid formation was performed as described previously (Li et al., 2016). Briefly, to form cellular aggregates, OSR1+SIX2+
progenitor cells were sorted by a FACS Aria II and plated in spindle-shaped bottom low adhesion 96-well plates (SUMITOMO BAKE-
LITE) at a density of 1.0 3 105 cells/well with basal medium supplemented with 10 mM Y-27632, 200 ng/ml FGF9 and 1 mM
CHIR99021. After 24 h of incubation, the aggregates were transferred onto transwell inserts (Corning) with KR5 medium (DMEM/
F12 Glutamax containing 0.1 mM non-essential amino acids (Thermo Fisher Scientific), 500 U/ml PS, 55 mM 2-mercaptoethanol
(Thermo Fisher Scientific) and 5% KSR) in the presence of 4.5 mM CHIR99021 and 200 ng/ml FGF2 (Peprotech). After 2 days of cul-
ture, the medium was refreshed with KR5 medium, and the aggregates were cultured for an additional 8 days.
Kidney Reconstruction In Vitro
For the reconstruction of kidney structures from hiPSC-derived NPs and UB cells, the differentiation protocol for NPs was slightly
modified to enhancematuration of the resultant tissues as follows. In brief, hiPSCs cultured under feeder-free conditionswere treated
with 5 mMCHIR99021 from Stage 2 to Stage 4. Day 8 NPs and day 9 UB tissues were dissociated into single cells by incubation with
Accumax at 37C for 10 min and gentle pipetting. The dissociated single cells were mixed, resuspended in DMEM/F12 Glutamax
medium containing 10 mM Y-27632, 100 ng/ml bFGF and 20% KSR and seeded into a 96-well low cell-binding U-bottom plate at
9.0 3 104 NPs and 3.0 3 104 UB cells/well to form aggregates. After 2 days, the formed NP and UB mixed aggregates were trans-
ferred onto a transwell insert in DMEM/F12 medium containing 100 ng/ml bFGF and 20% KSR. The plates were agitated using a
seesaw shaker (TAITEC). After 2 days, the medium was changed to DMEM/F12 medium containing 20% KSR. The medium was
thereafter changed every other day.
Kidney Reconstruction In Vivo
Day 8 NPs and day 9 UB tissues were dissociated into single cells by incubation with Accumax at 37C for 10 min and gentle pipet-
ting. The dissociated single cells were mixed, resuspended in DMEM/F12 Glutamax medium containing 10 mM Y-27632, 100 ng/ml
bFGF and 20% KSR and seeded into a 96-well low cell-binding U-bottom plate at 9.03 104 NPs and 3.03 104 UB cells/well to form
aggregates. After 2 days, mixed aggregates were harvested for transplantation.
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We slightly modified a previously reported transplantation method (Takebe et al., 2014). After implantation of themixed kidney pro-
genitor aggregates under kidney capsules of immunodeficient mice, 20 mL Matrigel was inserted to release tension and secure a
space for the aggregates (Sharmin et al., 2016). Then, we covered the grafted area with Seprafilm (Kakenseiyaku) to prevent post-
surgical adhesion.
Intravital Imaging
Ten days after transplantation, recipient mice were anesthetized with isoflurane. Tail vein injections of 3 mg Hoechst 33342 (Thermo
Fisher Scientific) were performed. Host kidney capsules were gently exposed. We observed the transplanted kidney organoids using
multiphoton microscopy (Nikon A1R MP). After identification of the grafted organoids, tail vein injections of 2-5 mg Rhodamine
B-conjugated dextran (70,000 MW) (Thermo Fisher Scientific) were performed to identify vessel lumens. Microscope-mounted hot
plates were used to prevent hypothermia.
QUANTIFICATION AND STATISTICAL ANALYSIS
RNA-seq Data Processing
For bulk RNA sequencing, total RNA was extracted using miRNeasy Mini Kit (QIAGEN). We prepared sequencing libraries using the
KAPA Stranded mRNA-Seq Kit (KAPA Biosystems). The libraries were sequenced in 100 cycle Single-Read mode of HiSeq2500. All
sequence reads were extracted in FASTQ format using BCL2FASTQ Conversion Software 1.8.4 in the CASAVA 1.8.2 pipeline.
The sequence reads were mapped to hg19 reference genes using Tophat v2.0.14 and were normalized and quantified using
RPKMforGenes, downloaded on 10 December 2012. Gene expression levels were represented by log2(RPKM+1). A heatmap of
the gene expressions was generated by the heatmap.2 function of the gplots 3.0.1 library in R 3.4.1. Hierarchal clustering was con-
ducted according to a previous report (Takasato et al., 2015).
Single-cell RNA-seq Data Processing
For single cell RNA sequencing, the isolation of single cells and preparation of a library with cell barcodes were conducted using the
ddSEQplatform (Bio-Rad Laboratories) and SureCell WTA 30 Library Prep Kit (Illumina). Sequencing was performed on an HiSeq2500
with paired 68-bp and 75-bp reads. Demultiplexing and conversion of BCL base call files to FASTQ format from BCL files were per-
formed using bcl2fastq v2.20.0.422. Alignment to the human reference genome hg19, filtering, debarcoding and UMI counting were
conducted using the Cell Ranger v2.1.0 pipeline (10X Genomics).
Image Quantification for %SIX2 (+) Cells
Day 11 NPs were dissociated and plated in flat-bottom 24-well plates (Greiner) at a density of 2.03 105 cells/well with basal medium
supplementedwith 10 mMY-27632, 200 ng/ml FGF9 and 1 mMCHIR99021. After 24 h of incubation, the cells were fixedwith 4%PFA/
PBS at room temperature for 15 min after a brief wash with PBS. Fixed cells were washed with PBS and then blocked with PBST/5%
normal donkey serum for 1 h at room temperature. The cells were then immunostained with SIX2 antibody and DAPI. Images were
captured at nine images per well by using BZ-X700 and analyzed with the analyze particle function (ImageJ) for (%) SIX2 (+) cells by
calculating the total number of SIX2(+) cells/DAPI(+) cells. The protocol for the image analysis was optimized using day 6 posterior PS
cells and day 11 NPs derived from an OSR1-GFP/SIX2-tdTomato reporter hiPSC line as negative and positive controls, respectively.
Statistical Analysis
Data are expressed as themean ±SEM. Student’s t tests were performed to compare themean values when the experimental design
was composed of two individual groups. One-way ANOVA and Bonferroni’s post hoc test (Figure S2I) or Tukey-Kramer post hoc test
(Table S3) were used for multiple group comparisons. Significant differences are labeled in the figures as *p < 0.05, **p < 0.01, and
***p < 0.001.
DATA AND CODE AVAILABILITY
The NCBI GEO accession number for the RNA sequencing data reported in this paper is GSE146119.
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